| 产品名称: | Coxsackievirus B1 antiserum V-028-501-560 |
|---|---|
| 商品货号: | TS213468 |
| Deposited As: | Coxsackievirus B1 |
| Agent: | Coxsackievirus B1 antiserum V-028-501-560 |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation: | Source of antibody: horse |
| Product Format: | freeze-dried 2.0 or 5.0 mL |
| Storage Conditions: | 4°C |
| Comments: | Immunogen: V-028-001-020
Source of antibody: horse
Propagated in: African green monkey kidney cells in tissue culture
Treatment: 1) Concentrated 10X by Mg-Al carbonate method; 2) 1M MgCl2 added |
| Name of Depositor: | NIH/NIAID |
| Source: | Horse immune serum prepared against Coxsackievirus B1 strain Conn. - 5. |
| References: | Rosen L, Kern J. Hemagglutination and hemagglutination-inhibition with Coxsackie B viruses. Proc. Soc. Exp. Biol. Med. 107: 626-628, 1961. PubMed: 13743341 Wenner HA, Lenahan MF. Propagation of group A Coxsackie viruses in tissue cultures. II. Some interactions between virus and mammalian cells. Yale J. Biol. Med. 34: 421-438, 1961. PubMed: 14006144 Wenner. . Am. J. Epidemiol. 82: 27-39, 1965. |